Hospitalizations in the United States Caused by ACS.

Slides:

Advertisements

Similar presentations

Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)

Advertisements

A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.

Cardiac Markers byN.X.. Cardiac Markers 1. After the loss of integrity of cardiac myocyte membranes, intracellular macromolecules diffuse into the interstitium.

TACTICS-TIMI 18 Economics & HRQOL Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy.

TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.

Antiplatelet Interventions in Acute Coronary Syndromes.

The Benefit of an Invasive Strategy in Women Versus Men with Non-ST-Elevation ACS: A Collaborative Meta-Analysis of Randomized Trials Michelle O’Donoghue,

The percentage of values for cardiac troponin (cTn)T associated with elevated values for a point-of-care assay with less sensitivity and precision: the.

Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: The thrombolysis in myocardial infarction risk score.

Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.

Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Small molecule glycoprotein IIb/IIIa receptor inhibitors.

Upfront Combination Therapy vs Step-Up Approach for PAH:

Figure 1 Flow diagram displaying the proportions of patients with troponin measurements available from all eligible patients and the resulting study population.

Survival probability (%)

Anti–Cardiac Troponin Autoantibodies Are Specific to the Conformational Epitopes Formed by Cardiac Troponin I and Troponin T in the Ternary Troponin Complex.

Johannes Schmid et al. JACC 2018;71:

Johannes Schmid et al. JACC 2018;71:

Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:

Anticoagulant Safety Remains a Problem Emergency Hospitalizations for Adverse Drug Events.

Learning Objectives. Learning Objectives Variable Response to Clopidogrel.

Part III Lessons Learned: A Master Class in High-Sensitivity Troponin A Global Perspective.

Cardiac Troponin.

Applying New Data in Practice:

Diagnostic Algorithms for ACS and High-Sensitivity Troponin

Emergency Management of NOAC Bleeding

Cardiac Biomarkers.

Advances in Coronary Artery Disease: Moving Beyond Antiplatelet Therapy.

Introduction Antiplatelet Agents ADP Receptor Antagonists.

تحليل الحساسية Sensitive Analysis.

Identifying Patients Suitable for Discharge After a Single-Presentation High-Sensitivity Troponin Result: A Comparison of Five Established Risk Scores.

Part II: It Takes a Team— Incorporating High-Sensitivity Troponin Into Clinical Care.

How and When to Decide on Revascularization in Stable Ischemic Heart Disease.

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Heart Failure Prevention: Mission Impossible?

Evaluating LDL-C Recommendations

Part I: A Sensible Approach to Sensitive Troponin

Nat. Rev. Cardiol. doi: /nrcardio

Selected Causes of Cardiac Injury PEACE Trial High-Sensitivity Biomarker Substudy.

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Advancing Acute Coronary Syndrome Assessment:

Section F: Clinical guidelines

New LDL-C Lipid Targets

Invasive versus conservative treatment in unstable coronary syndromes

Overcoming Clinical Inertia

Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.

Updates in Cardiovascular Medicine

Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Optimizing Accuracy of Laboratory Testing: Team-Based Strategies to Reduce Biotin Concerns.

TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI

The European Society of Cardiology Presented by RJ De Winter

T2DM, CV Risk, and Modulating Risk With Glucose-Lowering Strategies

Kevin R. King et al. BTS 2016;1:73-86

Nat. Rev. Cardiol. doi: /nrcardio

CAD and HF Often Coexist

Early Management of NSTE-ACS: From the ED to the Cath Lab

Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High- Sensitivity Cardiac Troponin I Yader Sandoval, MD, Stephen W. Smith,

Immunofluorescence of polysulfone dialysis membranes.

Managing CLL With BTK Inhibitors

Improving Adherence to Antiplatelet Therapy After an ACS Event

Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients† T. Reynolds, M. Cecconi, P. Collinson, A.

Disease Burden of VTE Phases of VTE Treatment.

High-Sensitivity Troponin in Clinical Practice

Risk of mortality and fatal and nonfatal cardiovascular events in highest vs lowest quartiles for troponin T End point Relative risk 95% CI p Mortality.

Immunofluorescence of polysulfone haemodialysis membranes.

In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

ESC Guideline on the Management of STEMI Recommendation for DAPT

Figure 1 Novel markers of increased stroke risk in AF

High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery† P.G. Noordzij, O. van Geffen,

Analysis of receiver operating characteristic of three models (model 1: cardiac troponin T (cTnT), N-terminal pro brain natriuretic peptide (NT-proBNP),

Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.

Presentation transcript:

Hospitalizations in the United States Caused by ACS

The Birth of Cardiac Troponin cTnT in UA/NSTEMI

Troponin Establishing Its Prognostic Importance

Prognostic Use of a More Sensitive Current-Generation Assay

TACTICS-TIMI 18 Early Invasive (INV) vs TACTICS-TIMI 18 Early Invasive (INV) vs. Conservative (CON) Management and cTnI 30-Day Results

Use of a Lower Cut Point

Effect of Implementation of a Sensitive Assay for Troponin

Troponin Practical Tips

Take-home Points

References

References (cont)

References (cont)

Abbreviations

Abbreviations (cont)

Abbreviations (cont)